News tagged ‘BreastCancer’ clear
- Dana-Farber scientists have safely shut down breast cancer and a form of leukemia in mice by targeting abnormal proteins to which the cancers are "addicted."
Tags: BasicResearch, BreastCancer, Leukemia
- Pre-menopausal breast cancer survivors who were treated with
chemotherapy following surgery were more likely to have diminished
ovarian reserve compared to women who have never had breast cancer,
according to a study led by Dana-Farber investigators.
- Dana-Farber scientists have linked genetic variants to the regulation of genes involved in breast cancer, including four genes not previously implicated in breast cancer, shedding new insights into the biology of breast cancer.
Tags: BasicResearch, BreastCancer, Genomics
- A Dana-Farber study challenges the hypothesis that "cancer stem cells" —
a small number of self-renewing cells within a tumor — are responsible
for breast cancer progression and recurrence, and that wiping out these
cells alone could cure the disease.
Tags: BreastCancer, StemCellTransplant
- Although it sounds like a case of gender confusion on a molecular scale, the male hormone androgen spurs the growth of some breast tumors in women. In a new study, scientists at Dana-Farber Cancer Institute provide the first details of the cancer cell machinery that carries out the hormone’s relentless growth orders.
Tags: BasicResearch, BreastCancer
- A new discovery by Jean Zhao, PhD, and colleagues may help physicians predict which tumors are likely to become resistant to a given drug. In the report, published by Nature Medicine, researchers described how they created a genetically engineered mouse model of human breast cancer in which the most frequently occurring breast cancer oncogene, PIK3CA, could be turned on and off.
Tags: BreastCancer, Genomics, TargetedTherapy, Genetics
- Kornelia Polyak, MD, PhD, was presented with the 2012 AACR Outstanding Investigator Award for Breast Cancer Research at the 35th annual CTRC-AACR San Antonio Breast Cancer Symposium.
Tags: BasicResearch, BreastCancer, Honors
- In a new study examining disparities in postmastectomy breast
reconstruction, researchers at Brigham and Women's Hospital and
Dana-Farber concluded that lack of patient-provider discussion may
contribute to socioeconomic, age and race-related inconsistencies in the
use of breast reconstruction after mastectomy.
Tags: BreastCancer, Disparities
- Wendy Y. Chen, MD, MPH, a breast cancer expert at Dana-Farber, has conducted research that shows that food-based soy is safe to eat for breast cancer patients and survivors.
Tags: BreastCancer, Nutrition